All posts by: Michael Zand

About Michael Zand

How bone marrow niches keep stem cells thriving – Medical Xpress

Continue reading

2018-04-19 NEWS

Medical Xpress

How bone marrow niches keep stem cells thriving
Medical Xpress
“In the absence of Ebf3, the stem cell population dropped fairly sharply, consistent with CAR cells playing a major role HSC regulation,” Seike adds. “What we didn’t expect was the impact the removal would have on the shape of the niche itself. We

Continue reading

2018-04-19 NEWS

Cape Cod Times

‘Super Bowl of lung cancer immunotherapy
Cape Cod Times
Lung cancer is the second-most-common malignancy in the United States, after breast cancer. The American Cancer Society estimates that 234,000 people will be diagnosed with the disease this year, and 154,050 will die of it. Patients with newly
Immunotherapy-first cancer treatment a ‘game-changer’, say scientistsSt. Lucia Times Online News (press release)
New studies give hope to people with lung cancerKOB
Immune therapy scores big win against lung cancer in studyThe Philadelphia Tribune
The Wellesley News –Chemical & Engineering News
all 12 news articles »
Continue reading

2018-04-19 NEWS

Cape Cod Times

‘Super Bowl of lung cancer immunotherapy
Cape Cod Times
Lung cancer is the second-most-common malignancy in the United States, after breast cancer. The American Cancer Society estimates that 234,000 people will be diagnosed with the disease this year, and 154,050 will die of it. Patients with newly
Immunotherapy-first cancer treatment a ‘game-changer’, say scientistsSt. Lucia Times Online News (press release)
New studies give hope to people with lung cancerKOB
Immune therapy scores big win against lung cancer in studyThe Philadelphia Tribune
The Wellesley News –Chemical & Engineering News
all 12 news articles »